Loading…

A serological point-of-care test for Zika virus detection and infection surveillance using an enzyme-free vial immunosensor with a smartphone

Zika virus (ZIKV) is a mosquito-borne flavivirus (FLAV) that emerged in Brazil in 2015 and has rapidly spread to more than 50 countries worldwide. However, early, accurate, and specific point-of-care (POC) diagnosis of ZIKV is very difficult because most infected patients are asymptomatic or display...

Full description

Saved in:
Bibliographic Details
Published in:Biosensors & bioelectronics 2020-03, Vol.151, p.111960-111960, Article 111960
Main Authors: Hsu, Ying-Pei, Li, Nan-Si, Chen, Ying-Tzu, Pang, Hao-Han, Wei, Kuo-Chen, Yang, Hung-Wei
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Zika virus (ZIKV) is a mosquito-borne flavivirus (FLAV) that emerged in Brazil in 2015 and has rapidly spread to more than 50 countries worldwide. However, early, accurate, and specific point-of-care (POC) diagnosis of ZIKV is very difficult because most infected patients are asymptomatic or display nonspecific symptoms similar to those of other viral infections, and most of the analysis also requires instruments. Herein, an instrument-free ZIKV POC test using a drop of blood comprising a vial immunosensor, artificial nanozyme platinum/gold core-shell nanoparticles (Pt@Au NPs) as a signal probe, and a smartphone was developed to specifically detect ZIKV without cross-reaction with other FLAVs. A high sensitivity of 1 pg/mL ZIKV, desirable specificity, data storage, and geographic location surveillance were simultaneously achieved for the proposed POC test. Our POC test suitably met the urgent needs of ports of entry, airports, and endemic regions with stressed resources, as well as strict clinical requirements for ZIKV detection. •An instrument-free POC test for fast simple and quantitative Zika virus detection and infection surveillance.•A smartphone combined with a custom app was used to enable portable testing, data storage, and geographic location tagging.•The performance of the developed POC test was validated using spiked body fluids (urine, serum, and whole blood).•Man-made peroxidase-mimic nanozyme based on Pt@Au core-shell NPs presented high oxidability, stability, and low cost.•The ultrasensitive POC test could achieve a wide detection range of 1 pg/mL–1000 pg/mL ZIKV with an iPhone 7 plus.
ISSN:0956-5663
1873-4235
DOI:10.1016/j.bios.2019.111960